These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 27036015)

  • 1. The emerging role of FTY720 (Fingolimod) in cancer treatment.
    White C; Alshaker H; Cooper C; Winkler M; Pchejetski D
    Oncotarget; 2016 Apr; 7(17):23106-27. PubMed ID: 27036015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod.
    Patmanathan SN; Yap LF; Murray PG; Paterson IC
    J Cell Mol Med; 2015 Oct; 19(10):2329-40. PubMed ID: 26171944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
    Singh SK; Spiegel S
    Adv Biol Regul; 2020 Jan; 75():100670. PubMed ID: 31708456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.
    Ntranos A; Hall O; Robinson DP; Grishkan IV; Schott JT; Tosi DM; Klein SL; Calabresi PA; Gocke AR
    J Neuroimmunol; 2014 May; 270(1-2):13-21. PubMed ID: 24680062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTY720 requires vitamin B
    Jonnalagadda D; Kihara Y; Groves A; Ray M; Saha A; Ellington C; Lee-Okada HC; Furihata T; Yokomizo T; Quadros EV; Rivera R; Chun J
    Cell Rep; 2023 Dec; 42(12):113545. PubMed ID: 38064339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review.
    Cristóbal I; Madoz-Gúrpide J; Manso R; González-Alonso P; Rojo F; García-Foncillas J
    Curr Med Res Opin; 2016 Jun; 32(6):1137-41. PubMed ID: 26950691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azacyclic FTY720 Analogues That Limit Nutrient Transporter Expression but Lack S1P Receptor Activity and Negative Chronotropic Effects Offer a Novel and Effective Strategy to Kill Cancer Cells in Vivo.
    Chen B; Roy SG; McMonigle RJ; Keebaugh A; McCracken AN; Selwan E; Fransson R; Fallegger D; Huwiler A; Kleinman MT; Edinger AL; Hanessian S
    ACS Chem Biol; 2016 Feb; 11(2):409-14. PubMed ID: 26653336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CII-specific autoimmune T-cell response develops in the presence of FTY720 but is regulated by enhanced Treg cells that inhibit the development of autoimmune arthritis.
    Miller DC; Whittington KB; Brand DD; Hasty KA; Rosloniec EF
    Arthritis Res Ther; 2016 Jan; 18():8. PubMed ID: 26757712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration.
    Anastasiadou S; Knöll B
    Exp Neurol; 2016 May; 279():243-260. PubMed ID: 26980486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.
    Mazzola MA; Raheja R; Murugaiyan G; Rajabi H; Kumar D; Pertel T; Regev K; Griffin R; Aly L; Kivisakk P; Nejad P; Patel B; Gwanyalla N; Hei H; Glanz B; Chitnis T; Weiner HL; Gandhi R
    J Neuroinflammation; 2015 Dec; 12():245. PubMed ID: 26714756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis].
    Klatt J; Hartung HP; Hohlfeld R
    Nervenarzt; 2007 Oct; 78(10):1200-8. PubMed ID: 17668161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory Effects of Fingolimod (FTY720) on the Expression of Sphingolipid Metabolism-Related Genes in an Animal Model of Alzheimer's Disease.
    Jęśko H; Wencel PL; Lukiw WJ; Strosznajder RP
    Mol Neurobiol; 2019 Jan; 56(1):174-185. PubMed ID: 29687345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis.
    Lee CW; Choi JW; Chun J
    Arch Pharm Res; 2010 Oct; 33(10):1567-74. PubMed ID: 21052934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV.
    Geffin R; Martinez R; de Las Pozas A; Issac B; McCarthy M
    J Neurovirol; 2017 Dec; 23(6):808-824. PubMed ID: 28913617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
    Serdar M; Herz J; Kempe K; Lumpe K; Reinboth BS; Sizonenko SV; Hou X; Herrmann R; Hadamitzky M; Heumann R; Hansen W; Sifringer M; van de Looij Y; Felderhoff-Müser U; Bendix I
    Brain Behav Immun; 2016 Feb; 52():106-119. PubMed ID: 26456693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 (fingolimod) for relapsing multiple sclerosis.
    Horga A; Montalban X
    Expert Rev Neurother; 2008 May; 8(5):699-714. PubMed ID: 18457527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting L-Selectin Lymphocytes to Deliver Immunosuppressive Drug in Lymph Nodes for Durable Multiple Sclerosis Treatment.
    Zhao Y; Zhang J; Cheng X; Huang W; Shen S; Wu S; Huang Y; Nie G; Wang H; Qiu W
    Adv Sci (Weinh); 2023 Jul; 10(20):e2300738. PubMed ID: 37170724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic FTY720 Is a Specific and Potent Therapy for Hypertrophic Scars.
    Shi F; Cao X; Hu Z; Ma D; Guo D; Zhang J; Zhang C; Liu P; Qu S; Zhu J; Deng W; Tang B
    J Invest Dermatol; 2017 Jul; 137(7):1552-1561. PubMed ID: 28288846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fingolimod (FTY720) reduces viability and survival and increases histone H3 acetylation in medulloblastoma cells.
    Perla AS; Fratini L; Cardoso PS; de Farias CB; da Cunha Jaeger M; Roesler R
    Pediatr Hematol Oncol; 2020 Mar; 37(2):170-175. PubMed ID: 31826690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720 for cancer therapy (Review).
    Zhang L; Wang HD; Ji XJ; Cong ZX; Zhu JH; Zhou Y
    Oncol Rep; 2013 Dec; 30(6):2571-8. PubMed ID: 24100923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.